Glaub Kathleen Sereda 4
4 · IO Biotech, Inc. · Filed Nov 8, 2021
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Glaub Kathleen Sereda
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-11-04+21,295→ 21,295 totalExercise: $14.00Exp: 2031-11-04→ Common Stock (21,295 underlying)
Footnotes (1)
- [F1]These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.